These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32110286)

  • 1. Allogeneic hematopoietic stem-cell transplantation for myelofibrosis.
    Zhang L; Yang F; Feng S
    Ther Adv Hematol; 2020; 11():2040620720906002. PubMed ID: 32110286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic stem cell transplant vs.Janus kinase inhibition in the treatment of primary myelofibrosis or myelofibrosis after essential thrombocythemia or polycythemia vera.
    Alchalby H; Kröger N
    Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S36-41. PubMed ID: 25486953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic stem-cell transplantation for myelofibrosis.
    Lavi N; Rowe JM; Zuckerman T
    Curr Opin Hematol; 2017 Nov; 24(6):475-480. PubMed ID: 28832353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic haematopoietic stem cell transplantation for primary myelofibrosis and myelofibrosis evolved from other myeloproliferative neoplasms.
    Tamari R; Castro-Malaspina H
    Curr Opin Hematol; 2015 Mar; 22(2):184-90. PubMed ID: 25635756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic stem cell transplantation for myelofibrosis in 2012.
    McLornan DP; Mead AJ; Jackson G; Harrison CN
    Br J Haematol; 2012 May; 157(4):413-25. PubMed ID: 22463701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of allogeneic stem-cell transplant in myelofibrosis in the era of JAK inhibitors: a case-based review.
    Tiribelli M; Palandri F; Sant'Antonio E; Breccia M; Bonifacio M
    Bone Marrow Transplant; 2020 Apr; 55(4):708-716. PubMed ID: 31534197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Allogeneic Hematopoietic Stem Cell Transplantation in Primary Myelofibrosis.
    Wolfe HR; Horwitz ME; Rein LAM
    J Pers Med; 2022 Apr; 12(4):. PubMed ID: 35455686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How we manage JAK inhibition in allogeneic transplantation for myelofibrosis.
    Ballinger TJ; Savani BN; Gupta V; Kroger N; Mohty M
    Eur J Haematol; 2015 Feb; 94(2):115-9. PubMed ID: 25256963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors.
    Shanavas M; Popat U; Michaelis LC; Fauble V; McLornan D; Klisovic R; Mascarenhas J; Tamari R; Arcasoy MO; Davies J; Gergis U; Ukaegbu OC; Kamble RT; Storring JM; Majhail NS; Romee R; Verstovsek S; Pagliuca A; Vasu S; Ernst B; Atenafu EG; Hanif A; Champlin R; Hari P; Gupta V
    Biol Blood Marrow Transplant; 2016 Mar; 22(3):432-40. PubMed ID: 26493563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving allogeneic stem cell transplantation in myelofibrosis.
    Gagelmann N; Kröger N
    Int J Hematol; 2022 May; 115(5):619-625. PubMed ID: 35419771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Patriarca F; Bacigalupo A; Sperotto A; Isola M; Soldano F; Bruno B; van Lint MT; Iori AP; Santarone S; Porretto F; Pioltelli P; Visani G; Iacopino P; Fanin R; Bosi A;
    Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019.
    McLornan DP; Yakoub-Agha I; Robin M; Chalandon Y; Harrison CN; Kroger N
    Haematologica; 2019 Apr; 104(4):659-668. PubMed ID: 30872371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies and dilemmas in allogeneic transplantation for myelofibrosis.
    Shanavas M; Gupta V
    Best Pract Res Clin Haematol; 2014 Jun; 27(2):165-74. PubMed ID: 25189727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
    Barosi G; Bacigalupo A
    Curr Opin Hematol; 2006 Mar; 13(2):74-8. PubMed ID: 16456372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allogeneic hematopoietic stem cell transplantation for myeloproliferative neoplasms].
    Takenaka K
    Rinsho Ketsueki; 2019; 60(9):1148-1156. PubMed ID: 31597838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statement.
    Sliwa T; Beham-Schmid C; Burgstaller S; Buxhofer-Ausch V; Gastl G; Geissler K; Krauth M; Krippl P; Lang A; Petzer A; Wöhrer S; Wölfler A; Gisslinger H
    Wien Klin Wochenschr; 2017 May; 129(9-10):293-302. PubMed ID: 27966016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Challenges in Stem Cell Transplantation in Myelofibrosis.
    Kröger N
    Curr Hematol Malig Rep; 2015 Dec; 10(4):344-50. PubMed ID: 26285891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic hematopoietic stem cell transplantation for myelofibrosis and chronic myelomonocytic leukemia.
    Kekre N; Ho VT
    Am J Hematol; 2016 Jan; 91(1):123-30. PubMed ID: 26453238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leveraging JAK-STAT regulation in myelofibrosis to improve outcomes with allogeneic hematopoietic stem-cell transplant.
    Byrne M; Savani B; Savona MR
    Ther Adv Hematol; 2018 Sep; 9(9):251-259. PubMed ID: 30210754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Stem Cell Therapy in Myelofibrosis.
    Davidson MB; Gupta V
    Hematol Oncol Clin North Am; 2021 Apr; 35(2):391-407. PubMed ID: 33641876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.